RecruitingNCT05392881
Interstitial Lung Disease Research Unit Biobank
Studying Hypersensitivity pneumonitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Kansas Medical Center
- Principal Investigator
- Scott Matson, M.D.University of Kansas Medical Center
- Enrollment
- 1000 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2032
Study locations (1)
- The University of Kansas Medical Center, Kansas City, Kansas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05392881 on ClinicalTrials.govOther trials for Hypersensitivity pneumonitis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06811389Reimagining Interventions for Support and Education in Hypersensitivity PneumonitisWeill Medical College of Cornell University
- RECRUITINGNCT06644144P4O2 ILD ExtensionAmsterdam UMC, location VUmc
- RECRUITINGNANCT03800017Skeletal Muscle Function in Interstitial Lung DiseaseUniversity of British Columbia
- RECRUITINGNCT05549635Database and Biobank of Patients With Hypersensitivity PneumonitisNils Hoyer
- RECRUITINGEARLY PHASE1NCT05365802FAPI PET for Lung FibrosisUniversity of California, Los Angeles
- ACTIVE NOT RECRUITINGNCT04844359A Prognostic Transcriptomic Signature for Chronic Hypersensitivity PneumonitisNational Jewish Health
- ACTIVE NOT RECRUITINGNCT03747627BPF Genetics of ILD StudyUniversity of Dundee
- ENROLLING BY INVITATIONNCT04896138University of Virginia Natural History StudyUniversity of Virginia